Chapter 1: Drugs and Cosmetics Act, 1940

UNIT 5 — FORENSIC PHARMACY AND DRUG REGULATORY AFFAIRS

CHAPTER 1: DRUGS AND COSMETICS ACT, 1940

Introduction, Legislative Framework, Sections 1–3 and Statutory Definitions

Examination: Uttar Pradesh Drug Inspector
Paper: Pharmacy Subjects / Subject-Specific Knowledge
Unit: Unit 5 — Forensic Pharmacy and Drug Regulatory Affairs
Material type: Complete Master Notes
Level: Competitive Examination Preparation

---

1. INTRODUCTION TO THE DRUGS AND COSMETICS ACT, 1940

The Drugs and Cosmetics Act, 1940 (Act No. 23 of 1940) is a central legislation governing the import, manufacture, distribution and sale of drugs and cosmetics in India.

The long title of the Act identifies its principal regulatory purpose: regulating the import, manufacture, distribution and sale of drugs and cosmetics.

The Act must be studied alongside the Drugs and Cosmetics Rules, 1945, applicable amendments, Gazette notifications and other relevant legislation.

1.1 Essential statutory facts

Examination point: The enactment date of the Act must not be confused with the commencement date of an individual chapter or a subsequent amendment.

1.2 Objectives of the Act

The Act establishes a statutory framework for regulating drugs and cosmetics to protect public health and ensure compliance with applicable legal requirements.

Its principal regulatory areas include

1. Regulation of the import of drugs and cosmetics.
2. Regulation of their manufacture, sale and distribution.
3. Establishment and enforcement of standards of quality under applicable provisions.
4. Regulation of specified product categories and prohibited activities.
5. Control of labelling and packing requirements.
6. Provision for inspection, sampling and analysis.
7. Enforcement through statutory powers, offences and penalties specified in the legislation.

These points are an explanatory summary of the Act's regulatory framework, not a verbatim statutory list of objectives.

1.3 Importance of the Act for a Drug Inspector

A Drug Inspector may need to examine whether:

• A drug is being manufactured in accordance with applicable legal requirements.
• The relevant manufacturing or sale licence is valid and its conditions are satisfied.
• A product complies with applicable standards of quality.
• Labelling and packaging comply with the relevant requirements.
• A product falls within a prohibited or restricted category.
• Sampling, inspection and testing are undertaken according to the applicable legal procedure.
• A suspected contravention warrants further regulatory action under the relevant provisions.

Important: A Drug Inspector's powers are statutory. They must be exercised within the scope of the relevant appointment, provisions and applicable rules.

---

2. SCOPE OF THE ACT

The scope of the Act can be understood through the principal activities and regulatory controls it addresses.

The exact requirements for a particular product or activity must be determined from the applicable section, rule, schedule, amendment and notification.

2.1 The Act and the Rules: distinction

Examination trap: A section of the Act and a rule or schedule of the Rules are not interchangeable legal references.

---

3. SECTION 1 — SHORT TITLE, EXTENT AND COMMENCEMENT

Section 1 deals with three distinct matters

1. Short title.
2. Extent.
3. Commencement.

3.1 Section 1(1): Short title

The legislation may be called the Drugs and Cosmetics Act, 1940.

3.2 Section 1(2): Extent

The Act extends to the whole of India.

3.3 Section 1(3): Commencement

Section 1(3) provides for the Act to come into force at once, subject to special commencement arrangements for Chapters III and IV.

Chapter III — Import of drugs and cosmetics

The commencement provision links the chapter's commencement to a date appointed by the Central Government by notification in the Official Gazette.

Chapter IV — Manufacture, sale and distribution of drugs and cosmetics

The provision specifies commencement arrangements involving the State Government and notification in the Official Gazette.

The statutory text also contains a historical proviso concerning Jammu and Kashmir. Historical commencement questions should be answered using the applicable amended statutory text.

3.4 Section 1: examination table

3.5 Common examination traps

---

4. SECTION 2 — APPLICATION OF OTHER LAWS NOT BARRED

Section 2 provides that the provisions of the Drugs and Cosmetics Act are “in addition to, and not in derogation of” the Dangerous Drugs Act, 1930, and any other law for the time being in force.

4.1 Meaning in simple English

The Drugs and Cosmetics Act does not automatically replace or displace every other applicable law.

More than one statute may apply to the same facts, depending on the substance, activity and relevant legal provisions.

For example, a case involving a controlled substance may require consideration of the Narcotic Drugs and Psychotropic Substances Act, 1985, alongside applicable provisions of the Drugs and Cosmetics Act.

4.2 Examination point

Memorise the expression

“In addition to, and not in derogation of.”

This is the key phrase associated with Section 2.

The section preserves the application of other relevant laws rather than making the Drugs and Cosmetics Act an exclusive legal code.

---

5. BASIC STRUCTURE OF THE DRUGS AND COSMETICS ACT

The following chapter-wise framework provides a foundation for studying the Act.

Memorisation strategy: Learn each chapter number with its subject. Add the relevant sections, rules, authorities, exceptions and penalties as each topic is studied.

5.1 Important regulatory bodies

DTAB — Drugs Technical Advisory Board

The DTAB is associated with the provisions in Section 5 of the Act.

CDL — Central Drugs Laboratory

The Central Drugs Laboratory is an important statutory laboratory in the regulatory framework.

DCC — Drugs Consultative Committee

The DCC is another statutory body addressed in Chapter II.

The composition, functions and statutory powers of these bodies must be studied separately. They do not have interchangeable functions.

---

PART B — SECTION 3: DEFINITIONS

6. INTRODUCTION TO SECTION 3

Section 3 begins with the interpretive qualification

“In this Act, unless there is anything repugnant in the subject or context,—”

This means that the statutory definitions generally apply unless the subject or context requires a different interpretation.

Section 3 contains definitions used throughout the Act. These definitions are important because the scope of a statutory term determines how the relevant legal provisions apply.

7. SECTION 3: DEFINITION CHECKLIST

The operative definition framework includes the following principal terms:

Historical clause letters that have been omitted or deleted must not be treated as current definitions. Always consult the applicable statutory text.

---

8. SECTION 3(a) — AYURVEDIC, SIDDHA OR UNANI DRUG

The definition covers medicines intended for internal or external use for the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, manufactured according to the statutory requirements concerning formulae described in authoritative books of the relevant systems specified in the First Schedule.

Important examination points

• Internal and external use are covered.
• The definition includes diagnosis, treatment, mitigation and prevention.
• The relevant authoritative books are important.
• The First Schedule must be studied in connection with the definition.
• The statutory manufacturing requirements must be satisfied.

Examination trap: Every herbal product must not automatically be classified as an Ayurvedic, Siddha or Unani drug under this definition. The applicable statutory conditions must be met.

---

9. SECTION 3(aa) — THE BOARD

This definition distinguishes between the relevant Boards for two categories of products.

9.1 Ayurvedic, Siddha or Unani drugs

The relevant body is the Ayurvedic, Siddha and Unani Drugs Technical Advisory Board constituted under Section 33C.

9.2 Other drugs or cosmetics

The relevant body is the Drugs Technical Advisory Board constituted under Section 5.

Examination trap: Do not treat the two Boards as interchangeable bodies. Their statutory composition and functions require separate study.

---

10. SECTION 3(aaa) — COSMETIC

The definition covers an article intended to be rubbed, poured, sprinkled, sprayed, introduced into or otherwise applied to the human body or any part thereof for:

1. Cleansing.
2. Beautifying.
3. Promoting attractiveness.
4. Altering appearance.

It also includes an article intended for use as a component of a cosmetic, subject to the statutory text.

Examination points

• The intended application and purpose are important.
• The definition includes cosmetic components.
• A product is not automatically a cosmetic merely because it is applied to the skin.
• Classification must follow the statutory definition and applicable regulatory requirements.

---

11. SECTION 3(b) — DRUG

The definition of drug is particularly important because it contains several inclusive clauses.

11.1 Section 3(b)(i): Medicines and disease-related substances

This clause includes medicines for internal or external use in human beings or animals and substances intended for the diagnosis, treatment, mitigation or prevention of disease or disorder.

The clause expressly includes preparations applied to the human body to repel insects such as mosquitoes.

Examination trap: Insect-repellent preparations are specifically mentioned in the statutory definition.

11.2 Section 3(b)(ii): Certain substances affecting structure or function

This clause covers specified non-food substances intended to affect the structure or a function of the human body, or intended for the destruction of vermin or insects that cause disease, where specified by the Central Government through notification in the Official Gazette.

Examination trap: The notification requirement is part of the statutory clause and must not be omitted from an explanation of its scope.

11.3 Section 3(b)(iii): Components of a drug

This clause includes substances intended for use as components of a drug.

It expressly includes empty gelatin capsules.

High-priority fact: Empty gelatin capsules are included within Section 3(b)(iii).

11.4 Section 3(b)(iv): Certain medical devices

This clause includes devices intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in humans or animals, where specified by the Central Government through notification in the Official Gazette after consultation with the Board.

Important distinction: The statutory notification requirement must be retained when interpreting this clause. Do not generalise it to mean that every healthcare device is covered solely because of its use.

Medical devices must also be studied alongside the applicable Medical Devices Rules, 2017.

11.5 Consolidated table: definition of drug

---

12. SECTION 3(c) — GOVERNMENT ANALYST

The definition distinguishes between two categories.

• For Ayurvedic, Siddha or Unani drugs, the relevant Government Analyst is appointed under Section 33F.
• For other drugs or cosmetics, the relevant Government Analyst is appointed under Section 20.

Examination trap: Do not interchange Sections 20 and 33F.

The detailed functions, qualifications and procedures associated with Government Analysts must be studied with the applicable provisions and Rules.

---

13. SECTION 3(e) — INSPECTOR

The definition distinguishes between

• An Inspector appointed under Section 33G for Ayurvedic, Siddha or Unani drugs.
• An Inspector appointed under Section 21 for other drugs or cosmetics.

Important examination distinction

A Government Analyst and an Inspector are separate statutory roles.

Their appointment provisions, duties and functions must not be confused.

---

14. SECTION 3(f) — MANUFACTURE

In relation to a drug or cosmetic, manufacture includes any process or part of a process for:

• Making.
• Altering.
• Ornamenting.
• Finishing.
• Packing.
• Labelling.
• Breaking up.
• Otherwise treating or adopting the product.

The statutory definition connects these processes with a view to sale or distribution.

The definition excludes the compounding or dispensing of a drug, and the packing of a drug or cosmetic, in the ordinary course of retail business.

Important examination points

1. Manufacture is broader than producing a drug from raw materials.
2. Packing and labelling are expressly included in the definition.
3. The purpose of sale or distribution is relevant.
4. The retail-business exclusion must be interpreted within its precise statutory scope.

Application-based example

A business alters and labels a drug with a view to distributing it. Such activities may fall within the broad definition of manufacture. The exact legal consequences depend on the facts and applicable licensing provisions.

Examination trap: Do not interpret the retail-business exclusion as a general exemption for every packaging or manufacturing activity.

---

15. SECTION 3(g) — TO IMPORT

The expression “to import” means to bring into India.

Examination points

• Importation is a principal regulatory subject under the Act.
• The definition is short and should be memorised.
• Detailed import restrictions and licensing requirements are covered under Chapter III and the applicable Rules.

---

16. SECTION 3(h) — PATENT OR PROPRIETARY MEDICINE

The definition distinguishes between Ayurvedic, Siddha or Unani systems and other systems of medicine.

16.1 Ayurvedic, Siddha or Unani systems

The definition covers specified formulations containing ingredients mentioned in formulae described in authoritative books identified in the First Schedule.

The definition contains exclusions and qualifications, including provisions concerning parenteral medicines and formulations covered by the relevant classical-drug definition.

16.2 Other systems of medicine

The definition covers a remedy or prescription presented in a form ready for internal or external administration to humans or animals, which is not included in the relevant edition of the Indian Pharmacopoeia or another pharmacopoeia authorised by the Central Government after consultation with the Drugs Technical Advisory Board.

Examination traps

• The definition contains separate limbs for ASU and other systems of medicine.
• Specific statutory conditions and exclusions apply.
• The authorised pharmacopoeia reference is relevant to the second limb.
• The expression must not be reduced to “any branded medicine.”

Study instruction: For a question requiring the exact legal definition, use the applicable consolidated statutory wording rather than a paraphrase.

---

17. SECTION 3(i) — PRESCRIBED

“Prescribed” means prescribed by rules made under the Act.

Examination application

When a provision states that a matter is to be prescribed, the relevant Rules must be consulted to identify the applicable requirement.

Do not assume that every operational detail appears directly in the Act.

---

PART C — SECTION MAPPING AND RAPID REVISION

18. Important statutory cross-references

These cross-references should be memorised together.

19. Rapid revision: one-line facts

1. Act number: 23 of 1940.
2. Enactment date: 10 April 1940.
3. Section 1: Short title, extent and commencement.
4. Section 2: Application of other laws not barred.
5. Section 3: Definitions.
6. Section 3(aaa): Cosmetic.
7. Section 3(b): Drug.
8. Section 3(c): Government Analyst.
9. Section 3(e): Inspector.
10. Section 3(f): Manufacture.
11. Section 3(g): To import.
12. Section 3(i): Prescribed.
13. Empty gelatin capsules: Expressly included under Section 3(b)(iii).
14. Section 20: Government Analyst for other drugs and cosmetics.
15. Section 21: Inspector for other drugs and cosmetics.
16. Section 33F: Government Analyst for ASU drugs.
17. Section 33G: Inspector for ASU drugs.

---

PART D — PRACTICE QUESTION BANK

20. Instructions

The following are original practice questions prepared from the concepts covered in this chapter. They are not represented as authenticated previous-year questions.

Choose the single best answer for each question. Check the answer key only after attempting all questions.

Question 1

The Drugs and Cosmetics Act, 1940 is

1. Act No. 23 of 1940
2. Act No. 23 of 1945
3. Act No. 10 of 1940
4. Act No. 21 of 1940

Question 2

Which section deals with the application of other laws not barred?

1. Section 1
2. Section 2
3. Section 3
4. Section 5

Question 3

Which clause defines cosmetic?

1. Section 3(a)
2. Section 3(aa)
3. Section 3(aaa)
4. Section 3(c)

Question 4

Empty gelatin capsules are expressly included under

1. Section 3(b)(i)
2. Section 3(b)(ii)
3. Section 3(b)(iii)
4. Section 3(b)(iv)

Question 5

A Government Analyst for other drugs or cosmetics is appointed under:

1. Section 20
2. Section 21
3. Section 33F
4. Section 33G

Question 6

An Inspector for Ayurvedic, Siddha or Unani drugs is appointed under:

1. Section 5
2. Section 20
3. Section 21
4. Section 33G

Question 7

Which activity is expressly included in the definition of manufacture?

1. Only synthesis of an active ingredient
2. Packing and labelling with a view to sale or distribution
3. Only dispensing a prescription
4. Only clinical testing

Question 8

The statutory expression “to import” means

1. To manufacture in India
2. To distribute between Indian States
3. To bring into India
4. To export from India

Question 9

The term “prescribed” means

1. Specified in a textbook
2. Prescribed by rules made under the Act
3. Approved by a retailer
4. Chosen by the manufacturer

Question 10

Section 3(aa) distinguishes between

1. Retail and wholesale licences
2. Central and State pharmacopoeias
3. The DTAB and the ASU Drugs Technical Advisory Board
4. Government hospitals and private hospitals

Question 11

Section 1(2) states that the Act extends to

1. Only Union Territories
2. Only notified States
3. The whole of India
4. Only central government institutions

Question 12

Which statement about Section 3(b)(iv) is most accurate?

1. It covers every device without conditions.
2. It concerns specified devices and includes a notification requirement.
3. It applies only to cosmetics.
4. It defines the Government Analyst.

Question 13

Which of the following is the key phrase associated with Section 2?

1. In the ordinary course of retail business
2. In addition to, and not in derogation of
3. For internal use only
4. Subject to the manufacturer's discretion

Question 14

Which chapter primarily concerns the import of drugs and cosmetics?

1. Chapter I
2. Chapter II
3. Chapter III
4. Chapter V

Question 15

Which statement correctly distinguishes the Act from the Rules?

1. Both are identical legal instruments.
2. The Rules eliminate the need to read the Act.
3. The Act and Rules are distinct instruments and must be read together where applicable.
4. Only the Rules have legal relevance.

Question 16

Which of the following is expressly included in the definition of manufacture, subject to the statutory qualifications?

1. Labelling
2. Only clinical diagnosis
3. Only patient counselling
4. Only retail dispensing

Question 17

Which provision is associated with the Government Analyst for ASU drugs?

1. Section 5
2. Section 20
3. Section 33F
4. Section 33G

Question 18

Which provision is associated with the Inspector for other drugs and cosmetics?

1. Section 20
2. Section 21
3. Section 33F
4. Section 33G

Question 19

Which statement about the definition of drug is correct?

1. It includes only finished tablets and capsules.
2. It excludes all substances intended for disease prevention.
3. It includes multiple categories specified under Section 3(b).
4. It applies only to medicines for human use.

Question 20

Which source should be preferred when verifying the exact wording of a statutory provision?

1. An unattributed coaching note
2. A social-media post
3. The applicable official statutory text and amendments
4. An unsourced MCQ compilation

---

21. ANSWER KEY WITH EXPLANATIONS

Performance interpretation

These bands are study recommendations, not official examination cut-offs.

---

PART E — CHAPTER COMPLETION CHECKLIST

22. Student self-assessment

Mark each item after completing the corresponding study task.

• [ ] I know the Act number and enactment date.
• [ ] I understand the objectives and scope of the Act.
• [ ] I can explain Section 1(1), Section 1(2) and Section 1(3).
• [ ] I understand Section 2 and its key phrase.
• [ ] I can distinguish the Act from the Rules.
• [ ] I know the basic chapter structure of the Act.
• [ ] I can explain the definitions listed in Section 3.
• [ ] I can identify the four clauses under Section 3(b).
• [ ] I can distinguish the relevant Boards for ASU and other drugs.
• [ ] I know the statutory cross-references for Inspectors and Government Analysts.
• [ ] I understand the definition of manufacture and its retail-business exclusion.
• [ ] I have attempted all 20 practice questions.
• [ ] I have reviewed every incorrect answer.

---

PART F — REFERENCES AND LEGAL VERIFICATION

23. Authoritative reference sources

1. India Code — Drugs and Cosmetics Act, 1940:

https://www.indiacode.nic.in/indiacode/handle/123456789/2409?view_type=browse

1. India Code — published Act PDF:

https://www.indiacode.nic.in/bitstream/123456789/15365/1/drug_%26_cosmetic_act.pdf

1. CDSCO — Acts and Rules repository:

https://www.cdsco.gov.in/opencms/opencms/en/Acts-and-rules/

1. CDSCO — Drugs Rules, 1945 and related notifications:

https://cdsco.mohfw.gov.in/opencms/opencms/en/Acts-and-rules/Drugs-Rules/

1. CDSCO — Gazette notifications:

https://www.cdsco.gov.in/opencms/opencms/en/Notifications/Gazette-Notifications/

Legal currency note

Older consolidated versions of the Act and Rules may not include every subsequent amendment. For a question requiring the current legal position, verify the applicable section or rule against the relevant amendment and Gazette notification.

The material above is intended for competitive-examination preparation. For a verbatim legal answer, always consult the applicable statutory wording.

---

CHAPTER 1 — FINAL LEARNING OBJECTIVE

After completing this chapter, students should be able to explain the purpose and scope of the Drugs and Cosmetics Act, distinguish the Act from its Rules, identify the main statutory chapters, interpret Sections 1–3 at an introductory level, recall the important definitions and cross-references, and solve basic legal-definition questions relevant to Drug Inspector examinations.

Next chapter in the series: Drugs Technical Advisory Board (DTAB), Central Drugs Laboratory (CDL) and Drugs Consultative Committee (DCC) — statutory provisions, composition, functions, differences and examination practice.